Literature DB >> 25785976

A new antibiotic and the evolution of resistance.

Cesar A Arias, Barbara E Murray.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25785976      PMCID: PMC4433155          DOI: 10.1056/NEJMcibr1500292

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  Drugs for bad bugs: confronting the challenges of antibacterial discovery.

Authors:  David J Payne; Michael N Gwynn; David J Holmes; David L Pompliano
Journal:  Nat Rev Drug Discov       Date:  2006-12-08       Impact factor: 84.694

2.  Use of ichip for high-throughput in situ cultivation of "uncultivable" microbial species.

Authors:  D Nichols; N Cahoon; E M Trakhtenberg; L Pham; A Mehta; A Belanger; T Kanigan; K Lewis; S S Epstein
Journal:  Appl Environ Microbiol       Date:  2010-02-19       Impact factor: 4.792

3.  A new antibiotic kills pathogens without detectable resistance.

Authors:  Losee L Ling; Tanja Schneider; Aaron J Peoples; Amy L Spoering; Ina Engels; Brian P Conlon; Anna Mueller; Till F Schäberle; Dallas E Hughes; Slava Epstein; Michael Jones; Linos Lazarides; Victoria A Steadman; Douglas R Cohen; Cintia R Felix; K Ashley Fetterman; William P Millett; Anthony G Nitti; Ashley M Zullo; Chao Chen; Kim Lewis
Journal:  Nature       Date:  2015-01-07       Impact factor: 49.962

4.  10 x '20 Progress--development of new drugs active against gram-negative bacilli: an update from the Infectious Diseases Society of America.

Authors:  Helen W Boucher; George H Talbot; Daniel K Benjamin; John Bradley; Robert J Guidos; Ronald N Jones; Barbara E Murray; Robert A Bonomo; David Gilbert
Journal:  Clin Infect Dis       Date:  2013-04-17       Impact factor: 9.079

  4 in total
  17 in total

1.  The Microbiome, Antibiotics, and Health of the Pediatric Population.

Authors:  Ravi S Misra
Journal:  EC Microbiol       Date:  2016-03

2.  Antibiotic discovery is a walk in the park.

Authors:  Louis-Félix Nothias; Rob Knight; Pieter C Dorrestein
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-09       Impact factor: 11.205

Review 3.  Antimicrobial hydrogels: promising materials for medical application.

Authors:  Kerong Yang; Qing Han; Bingpeng Chen; Yuhao Zheng; Kesong Zhang; Qiang Li; Jincheng Wang
Journal:  Int J Nanomedicine       Date:  2018-04-12

4.  The Human Microbiome and Public Health: Social and Ethical Considerations.

Authors:  Kieran C O'Doherty; Alice Virani; Elizabeth S Wilcox
Journal:  Am J Public Health       Date:  2016-01-21       Impact factor: 9.308

5.  De Novo Resistance to Arg10-Teixobactin Occurs Slowly and Is Costly.

Authors:  Daniel G Lloyd; Benjamin J Schofield; Matthew R Goddard; Edward J Taylor
Journal:  Antimicrob Agents Chemother       Date:  2020-12-16       Impact factor: 5.191

6.  A novel metabolomic approach used for the comparison of Staphylococcus aureus planktonic cells and biofilm samples.

Authors:  Laurence H Stipetic; Matthew J Dalby; Robert L Davies; Fraser R Morton; Gordon Ramage; Karl E V Burgess
Journal:  Metabolomics       Date:  2016-03-08       Impact factor: 4.290

Review 7.  Application of Omics Technologies for Evaluation of Antibacterial Mechanisms of Action of Plant-Derived Products.

Authors:  Bruno S Dos Santos; Luís C N da Silva; Túlio D da Silva; João F S Rodrigues; Marcos A G Grisotto; Maria T Dos Santos Correia; Thiago H Napoleão; Márcia V da Silva; Patrícia M G Paiva
Journal:  Front Microbiol       Date:  2016-09-27       Impact factor: 5.640

8.  Hormaomycins B and C: New Antibiotic Cyclic Depsipeptides from a Marine Mudflat-Derived Streptomyces sp.

Authors:  Munhyung Bae; Beomkoo Chung; Ki-Bong Oh; Jongheon Shin; Dong-Chan Oh
Journal:  Mar Drugs       Date:  2015-08-14       Impact factor: 5.118

9.  Signal Detection of Adverse Drug Reaction of Amoxicillin Using the Korea Adverse Event Reporting System Database.

Authors:  Mick Soukavong; Jungmee Kim; Kyounghoon Park; Bo Ram Yang; Joongyub Lee; Xue Mei Jin; Byung Joo Park
Journal:  J Korean Med Sci       Date:  2016-09       Impact factor: 2.153

10.  Targeting an Essential GTPase Obg for the Development of Broad-Spectrum Antibiotics.

Authors:  Josephine A Bonventre; Ryszard A Zielke; Konstantin V Korotkov; Aleksandra E Sikora
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.